Literature DB >> 15845624

Insulin-like growth factor (IGF)-I stimulates cell proliferation and induces IGF binding protein (IGFBP)-3 and IGFBP-5 gene expression in cultured growth plate chondrocytes via distinct signaling pathways.

Daniela Kiepe1, Sonia Ciarmatori, Andreas Hoeflich, Eckhard Wolf, Burkhard Tönshoff.   

Abstract

The bioactivity of IGF-I in the cellular microenvironment is modulated by both inhibitory and stimulatory IGF binding proteins (IGFBPs), whose production is partially under control of IGF-I. However, little is known on the IGF-mediated regulation of these IGFBPs in the growth plate. We therefore studied the effect of IGF-I on IGFBP synthesis and the involved intracellular signaling pathways in two cell culture models of rat growth plate chondrocytes. In growth plate chondrocytes in primary culture, incubation with IGF-I increased the concentrations of IGFBP-3 and IGFBP-5 in conditioned cell culture medium in a dose- and time-dependent manner. Coincubation of IGF-I with specific inhibitors of the p42/44 MAPK pathway (PD098059 or U0126) completely abolished the stimulatory effect of IGF-I on IGFBP-3 mRNA expression but did not affect increased IGFBP-5 mRNA levels. In contrast, inhibition of the phosphatidylinositol-3 kinase signaling pathway by LY294002 abrogated both IGF-I-stimulated IGFBP-3 and -5 mRNA expression. Comparable results regarding IGFBP-5 were obtained in the mesenchymal chondrogenic cell line RCJ3.1C5.18, which does not express IGFBP-3. The IGF-I-induced IGFBP-5 gene expression required de novo mRNA transcription and de novo protein synthesis. These data suggest that IGF-I modulates its activity in cultured rat growth plate chondrocytes by the synthesis of both inhibitory (IGFBP-3) and stimulatory (IGFBP-5) binding proteins. The finding that IGF-I uses different and only partially overlapping intracellular signaling pathways for the regulation of two IGFBPs with opposing biological functions might be important for the modulation of IGF bioactivity in the cellular microenvironment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845624     DOI: 10.1210/en.2005-0324

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

1.  IGF2-driven PI3 kinase and TGFbeta signaling pathways in chondrogenesis.

Authors:  Kazunori Hamamura; Ping Zhang; Hiroki Yokota
Journal:  Cell Biol Int       Date:  2008-07-16       Impact factor: 3.612

2.  Association between a functional polymorphism (-1195T>C) in the IGFBP5 promoter and head and neck cancer risk.

Authors:  Jiangong Niu; Yu-Jing Huang; Sheng Wei; Zhensheng Liu; Li-E Wang; Shine Chang; Robert M Chamberlain; Adel K El-Naggar; Erich M Sturgis; Qingyi Wei
Journal:  Head Neck       Date:  2010-10-14       Impact factor: 3.147

3.  Specific protein kinase C isoforms are required for rod photoreceptor differentiation.

Authors:  Carolina Pinzon-Guzman; Samuel Shao-Min Zhang; Colin J Barnstable
Journal:  J Neurosci       Date:  2011-12-14       Impact factor: 6.167

4.  Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy.

Authors:  Liping Zhang; Xiaonan H Wang; Huiling Wang; Jie Du; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

5.  Stimulatory effects of insulin-like growth factor-I on growth plate chondrogenesis are mediated by nuclear factor-kappaB p65.

Authors:  Shufang Wu; Doris Fadoju; Geoffrey Rezvani; Francesco De Luca
Journal:  J Biol Chem       Date:  2008-10-15       Impact factor: 5.157

6.  SCF, BDNF, and Gas6 are regulators of growth plate chondrocyte proliferation and differentiation.

Authors:  Michele R Hutchison; Mary H Bassett; Perrin C White
Journal:  Mol Endocrinol       Date:  2009-11-06

7.  Role of insulin-like growth factor-binding protein 5 (IGFBP5) in organismal and pancreatic beta-cell growth.

Authors:  Catherine E Gleason; Yun Ning; Tara P Cominski; Rana Gupta; Klaus H Kaestner; John E Pintar; Morris J Birnbaum
Journal:  Mol Endocrinol       Date:  2009-11-06

8.  Disruption of insulin-like growth factor-I expression in type IIalphaI collagen-expressing cells reduces bone length and width in mice.

Authors:  Kristen E Govoni; Seong Keun Lee; Yoon-Sok Chung; Richard R Behringer; Jon E Wergedal; David J Baylink; Subburaman Mohan
Journal:  Physiol Genomics       Date:  2007-05-22       Impact factor: 3.107

9.  Insulin-like growth factor 2 (IGF2) expression in adrenocortical disease due to PRKAR1A mutations compared to other benign adrenal tumors.

Authors:  Kiran S Nadella; Annabel Berthon; Madson Q Almeida; Isaac Levy; Fabio R Faucz; Constantine A Stratakis
Journal:  Endocrine       Date:  2021-01-09       Impact factor: 3.633

10.  Loss of PTEN selectively desensitizes upstream IGF1 and insulin signaling.

Authors:  J Lackey; J Barnett; L Davidson; I H Batty; N R Leslie; C P Downes
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.